BlackRock’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $27.8M | Buy |
|
|||||
|
2025
Q2 | $15M | Buy |
|
|||||
|
2025
Q1 | $7.76M | Sell |
|
|||||
|
2024
Q4 | $9.28M | Sell |
|
|||||
|
2024
Q3 | $27.4M | Buy |
|
|||||
|
2024
Q2 | $36.3M | Sell |
|
|||||
|
2024
Q1 | $58.1M | Sell |
|
|||||
|
2023
Q4 | $79.4M | Sell |
|
|||||
|
2023
Q3 | $63.6M | Buy |
|
|||||
|
2023
Q2 | $62.5M | Buy |
|
|||||
|
2023
Q1 | $53.8M | Buy |
|
|||||
|
2022
Q4 | $65.1M | Buy |
|
|||||
|
2022
Q3 | $85.5M | Buy |
|
|||||
|
2022
Q2 | $79.5M | Buy |
|
|||||
|
2022
Q1 | $119M | Buy |
|
|||||
|
2021
Q4 | $144M | Sell |
|
|||||
|
2021
Q3 | $224M | Sell |
|
|||||
|
2021
Q2 | $316M | Sell |
|
|||||
|
2021
Q1 | $241M | Buy |
|
|||||
|
2020
Q4 | $372M | Sell |
|
|||||
|
2020
Q3 | $154M | Buy |
|
|||||
|
2020
Q2 | $148M | Buy |
|
|||||
|
2020
Q1 | $83.1M | Sell |
|
|||||
|
2019
Q4 | $126M | Buy |
|
|||||
|
2019
Q3 | $93.8M | Buy |
|
|||||
|
2019
Q2 | $95.8M | Buy |
|
|||||
|
2019
Q1 | $92.6M | Buy |
|
|||||
|
2018
Q4 | $83.8M | Buy |
|
|||||
|
2018
Q3 | $114M | Buy |
|
|||||
|
2018
Q2 | $124M | Buy |
|
|||||
|
2018
Q1 | $94.9M | Buy |
|
|||||
|
2017
Q4 | $82.1M | Buy |
|
|||||
|
2017
Q3 | $63.4M | Buy |
|
|||||
|
2017
Q2 | $42.5M | Buy |
|
|||||
|
2017
Q1 | $25M | Buy |
|
|||||
|
2016
Q4 | $4K | Hold |
|
|||||
|
2016
Q3 | $4K | Hold |
|
|||||
|
2016
Q2 | $6K | Hold |
|
|||||
|
2016
Q1 | $9K | Buy |
|